Tp53 pathogenic variants in early-onset breast cancer patients fulfilling hereditary breast and ovary cancer and li-fraumeni-like syndromes

HIGHLIGHTS

• who: Paula Francinete Faustino da Silva and collaborators from the Laboratory of Molecular Genetics and Cytogenetics, Institute of Biological Sciences I (ICB I), Clinical of Hospital (HC), Federal University of Goiu00e1s (UFG), Goiu00e2nia, Brazil have published the article: TP53 Pathogenic Variants in Early-Onset Breast Cancer Patients Fulfilling Hereditary Breast and Ovary Cancer and Li-Fraumeni-like Syndromes, in the Journal: Biomolecules 2022, 12, 640. of /2022/
• what: We describe a low frequency (4.8%) of the TP53 germline pathogenic variants in the Midwest region of Brazil in breast cancer patients.

SUMMARY

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.